(Medical Xpress)—Researchers at the University of East Anglia (UEA) have made a discovery in neuroscience that could offer a long-lasting solution to eating disorders such as obesity.
Apr 5, 2013
0
0
Type 2 diabetes has strong hereditary tendencies and the genes we are born with cannot be changed. However, new research from Lund University in Sweden shows that we can modify the function of the genes through the epigenetic ...
Mar 19, 2013
0
0
(Medical Xpress)—Scientists have discovered the powerful role the molecule Myosin VI plays in communication between nerve cells in the brain.
Feb 4, 2013
0
1
New Zealand research revealing a new mechanism for how glucose stimulates insulin secretion may provide a new explanation for how a gene that makes people more susceptible to diabetes – called TCF7L2 – actually contributes ...
Feb 4, 2013
0
1
Sugars are needed to provide us with energy and in moderate amounts contribute to our well-being. Sustained high levels of sugars, as is found in diabetics, damages our cells and now is shown that can also increase our chance ...
Feb 1, 2013
10
0
A few years ago, manufacturers of water bottles, food containers, and baby products had a big problem. A key ingredient of the plastics they used to make their merchandise, an organic compound called bisphenol A, had been ...
Jan 22, 2013
1
1
Researchers at Karolinska Institutet in Sweden have managed to graft beta cells into the eyes of mice in order to study them in a living organism over a prolonged period of time. As a result, the group and a team of colleagues ...
Dec 10, 2012
0
0
(HealthDay)—The 32-mg, single intravenous dose of Zofran (ondansetron), an anti-nausea drug, is being removed from the market due to its potential to cause serious, even fatal, cardiac damage, according to a Drug Safety ...
Dec 6, 2012
0
0
Selective targeting of the neurotransmitter that differentially affects brain cells that control the two distinct functions of the pancreas may allow for new medication therapies for conditions like diabetes, dyspepsia and ...
Dec 4, 2012
0
0
(HealthDay)—Sustained release technologies for administering the opioid antagonist naltrexone (SRX) seem to be effective with an acceptable adverse event profile, according to a review published online Oct. 22 in the British ...
Nov 1, 2012
0
0
